Experimental Drug Development Centre
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10 Biopolis Chromos Rd 05-01, Singapore,...Website
www.eddc.sgRevenue
<$5 MillionIndustry
About Experimental Drug Development Centre
The Experimental Drug Development Centre (EDDC) is Singapore's national platform for drug discovery and development, collaborating with public sector and industry partners to translate scientific discoveries into biotherapeutic candidates. EDDC focuses on developing innovative therapeutics and companion diagnostics to improve patient outcomes, particularly for those with unmet medical needs. Their notable project, ETC-159, is a small molecule Wnt-porcupine inhibitor that has shown promise in clinical trials for patients with platinum-resistant ovarian cancer. EDDC welcomes partnerships to accelerate the development of their pipeline assets and enhance drug discovery efforts.Explore more
Experimental Drug Development Centre Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Experimental Drug Development Centre Tech Stack
A closer look at the technologies used by Experimental Drug Development Centre
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Experimental Drug Development Centre
Sign Up For FreeTo access detailed company insights
The Experimental Drug Development Centre (EDDC) is Singapore's national platform for drug discovery and development, collaborating with public sector and industry partners to translate scientific discoveries into biotherapeutic candidates. EDDC focuses on developing innovative therapeutics and companion diagnostics to improve patient outcomes, part... Read More
